BDSX
NASDAQ HealthcareBiodesix, Inc. - Common Stock
Diagnostics & Research
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. Further, it operates laboratories. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.
�� 市场数据
| 价格 | $29.20 |
|---|---|
| 成交量 | 100,864 |
| 市值 | 308.09M |
| 贝塔系数 | 0.590 |
| RSI（14日） | 60.4 |
| 200日均线 | $15.81 |
| 50日均线 | $24.16 |
| 52周最高 | $31.31 |
| 52周最低 | $5.26 |
| Forward P/E | -132.73 |
| Price / Book | 33.68 |
🎯 投资策略评分
BDSX 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🎈 Over-Hyped (86/100) — 此策略 超买股票（潜在做空标的）.
评分最低的策略： 🔪 Falling Knife (2/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 BDSX in your text
粘贴任何文章、记录或帖子 — 工具将提取 BDSX 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-09-18.